What is Kairos Pharma, Ltd.?
, a clinical-stage biopharmaceutical company, develops immunotherapy and cell therapies for the treatment of cancer.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biopharmaceutical company, develops immunotherapy and cell therapies for the treatment of cancer. The company offers therapeutics, including antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma. The company is listed on the AMEX in USA, operating in the Healthcare sector, with a market capitalisation of 2.04M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.